CorporateInformation.com
 
Company Search:
Advanced Search
 
Sponsored Links
 
 
 
 
 
 
 
Indivior Plc - ADR Company Snapshot
Indivior Plc operates in the Pharmaceutical preparations sector. In addition to historical fundamental analyses, the complete report available to purchase compares Indivior Plc with three other companies in this sector in the United States: Horizon Pharma PLC (2016 sales of $981.12 million of which 100% was Food & Drug Administration), Akorn, Inc. ($1.12 billion of which 94% was Prescription Pharmaceuticals), and Biomarin Pharmaceutical Inc ($1.12 billion of which 32% was Vimizim).

Sales Analysis. Indivior Plc reported sales of $1.06 billion for the year ending December of 2016. This represents an increase of 4.3% versus 2015, when the company's sales were $1.01 billion. Despite this increase, sales are still below the level achieved in 2014, when Indivior Plc reported sales of $1.12 billion.
   
   
 
  Stock Performance Chart for Indivior Plc - ADR
 
  Stock Data: Recent Stock Performance:
  Current Price (1/11/2018): 28.24
(Figures in U.S. Dollars)
1 Week 1.0%   13 Weeks 6.0%  
4 Weeks 25.1%   52 Weeks 51.3%  
 
Indivior Plc - ADR Key Data:
  Ticker: INVVY Country: United States
  Exchanges: OTC Major Industry: Pharmaceuticals & Biotechnology
    Sub Industry: Pharmaceutical Preparations
  2016 Sales 1,058,003,535
(Year Ending Jan 2017).
Employees: 934
  Currency: U.S. Dollars Market Cap: 4,074,821,516
  Fiscal Yr Ends: December Shares Outstanding: 144,292,547
  Share Type: Ordinary Closely Held Shares: 519,110
 
 
Sponsored Links
 
 
 
 
Feedback | Terms and Conditions | Privacy Policy | Site Index
 
CorporateInformation® website and selected data Copyright © 2000 - by The Winthrop Corporation. All Rights Reserved. Except for quotations by established news media, no pages on this site may be reproduced, stored in a retrieval system, or transmitted for commercial purposes, in any form or by any means, electronic, mechanical, photocopying, recording, or otherwise without prior written permission. Information is believed reliable, but accuracy, completeness and opinions are not guaranteed.